Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

How to Comply with Drug CGMPs

by Cathy L. Burgess
Save 15% Save 15%
Current price ₹16,651.00
Original price ₹19,502.00
Original price ₹19,502.00
Original price ₹19,502.00
(-15%)
₹16,651.00
Current price ₹16,651.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Paperback
  • ISBN13: 9781935065838
  • Binding: Paperback
  • Subject: N/A
  • Publisher: Food and Drug Law Institute
  • Publisher Imprint: Food and Drug Law Institute
  • Publication Date:
  • Pages: 102
  • Original Price: USD 199.0
  • Language: English
  • Edition: N/A
  • Item Weight: 259 grams
  • BISAC Subject(s): Administrative Law & Regulatory Practice, Reference, and Technical & Manufacturing Industries & Trades

Globalization in the pharmaceutical industry, expanded FDA authority over CGMPs, and increased scrutiny of data integrity, among other developments in this rapidly evolving field, make for a complex compliance environment.

This resource provides the legal community and regulated industry with a concise reference on the compliance standards and governing principles for current Good Manufacturing Practices.

Even as these standards will change over time, the underlying concepts discussed will help the reader understand these changes, and how to incorporate them into a robust compliance program.

Table of Contents
Introduction
I. What Are CGMPs?
A. Principles
B. Legal Framework
C. FDA Guidance to Industry
II How Does FDA Evaluate CGMP Compliance?
A. Establishment Inspections
B. Samples
C. Field Alert Reports
D. Adverse Event Reports and Consumer Complaints
E. Risk-Based Selection of Sites and Inspection Frequency/Rigor
F. Regulation of CGMPs for OTC Monograph and Homeopathic Drugs
III What Are the Consequences of Noncompliance?
A. Advisory Actions: Warning Letters, Untitled Letters and Regulatory Meetings
B. Import Detentions and Import Alerts
C. Recalls
D. Seizures
E. Injunctions
F. Criminal Prosecutions
G. False Claims Act and Qui Tam Investigations
H. Other Consequences
I. Certificates of Export/Government Contracts
J. Application Disapproval/Revocation
K. Application Integrity Policy

IV Recent CGMP Enforcement Activity
A. The Pattern of Enforcement
B. GlaxoSmithKline, PLC and its Subsidiary SB Pharmco Puerto Rico Inc.
C. Genzyme Corporation
D. Ranbaxy Laboratories Limited and its Subsidiary Ranbaxy USA Inc.
V How Do We Remain "Current" with CGMPs?

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us